Filing metadata

Accession number
0001493152-23-006669
Form type
Form 3
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Mar 03, 2023
Reporting period
Feb 23, 2023
Description
Initial ownership

Explore SEC Filings Hub